Company Syncro Clinical Research Srl with Fiscal Code 18281936
recorded a turnover of 2024 of
43.078,
with a net profit of
-11.475
and having an average number of employees of
2.
The company operates in the field of Activităţi de asistenţă medicală specializată having the NACE code 8622.
Sales - Ron
Sales, Profit, Employees, Total Income, Financial Results -
Syncro Clinical Research Srl
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Sales - EUR
124.226
223.323
188.880
153.953
96.575
67.895
138.938
111.337
67.117
43.078
Total Income - EUR
130.260
335.121
189.803
154.254
97.456
68.274
140.031
141.029
67.118
43.094
Total Expenses - EUR
119.388
253.336
121.874
112.590
99.780
37.565
33.379
81.694
47.699
53.411
Gross Profit/Loss - EUR
10.871
81.785
67.930
41.664
-2.324
30.709
106.652
59.335
19.419
-10.317
Net Profit/Loss - EUR
9.207
69.384
65.858
40.122
-3.299
30.068
105.562
58.355
18.990
-11.475
Employees
3
3
3
2
2
2
1
1
1
2
The table presents the most important indicators of the company from the Profit and Loss Account for the last 10 years of activity as found at the Ministry of Finance. The data provides the evolution of the company during this period regarding the increases and possibly decreases recorded.
In the last year of activity, the sales decreased by -35.5%, from 67.117 euro in the year 2023, to 43.078 euro in 2024.
The Net Profit decreased by -18.883 euro, from 18.990 euro in 2023, to 0 in the last year.
Check the financial reports for the company - Syncro Clinical Research Srl
Financial Rating - SYNCRO CLINICAL RESEARCH SRL
See the company's note based on the submitted financial data, relative to the industry of which it is a part.
Financial Rating
Payment Limits - Syncro Clinical Research Srl
See the company's payment capacity for situations in which you conclude contracts with payment terms.
Check Payment Limits
Prob. of insolvency - Syncro Clinical Research Srl
It determines the risk of insolvency based on the submitted accounting balance.
Insolvency Probability
Financial Reports - Syncro Clinical Research Srl
Check all the financial reports of the company and know the risks in collaboration with it.
Check Financial Reports
Financial Analysis Reports provide a clear and comprehensive view of a company's financial activity. In addition to presenting financial data, the reports analyze this data so that any user can understand whether the results are positive or less favorable. The Financial Rating provides an analysis based on the most important financial ratios, including liquidity, solvency, and profitability. Payment Limits represent the maximum amounts for which a company can offer goods or services on credit to its clients. The Probability of Insolvency presents the theoretical probability that a company may not be able to meet its financial obligations towards its creditors, i.e., suppliers and financial institutions.
Debts, Equity, Inventories, Receivables, Accounts, Assets -
Syncro Clinical Research Srl - CUI 18281936
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Fixed Assets
134.818
27.540
18.589
12.554
3.249
1.757
230.413
266.094
254.205
239.440
Current Assets
59.364
63.967
49.125
68.577
36.179
49.132
26.674
31.924
21.670
10.928
Inventories
0
0
0
15.254
0
0
0
223
0
0
Receivables
45.758
22.364
25.413
0
15.444
20.496
20.797
24.135
17.429
9.408
Cash
13.606
41.603
23.712
53.323
20.735
28.636
5.878
7.566
4.241
1.519
Shareholders Funds
150.681
69.437
65.911
40.173
29.774
49.827
109.009
167.703
186.184
173.668
Social Capital
45
45
44
43
42
41
40
41
40
40
Debts
44.229
22.070
1.804
40.957
9.654
1.062
148.078
130.316
89.691
76.699
Income in Advance
0
0
0
0
0
0
0
0
0
0
Exchange rate - RON
4.9743
4.9465
4.9315
4.9468
4.8371
4.7454
4.6535
4.5681
4.4908
4.445
Main CAEN
"8622 - 8622"
CAEN Financial Year
8621
The table presents the company's Balance Sheet structure for the last 10 years. Current Assets recorded a value of
10.928 euro in 2024 which includes Inventories of
0 euro, Receivables of
9.408 euro and cash availability of
1.519 euro.
The company's Equity was valued at
173.668 euro, while total Liabilities amounted to
76.699 euro.
Equity decreased by -11.475 euro, from 186.184 euro in 2023, to 173.668 in 2024.
Similar services useful for checking companies and business development.
SellNet
Get the contact details for any company and get in touch with it.
Sectoral Studies
Knows the market and develops its own development strategies according to sectorial data.
Databases
Export in excel files the data of the companies selected according to the desired criteria.
Import - Export
Find importers and exporters according to the type of activity and the countries in which they carry it out.
Similar services represent services associated with companies that allow for a better analysis of clients and suppliers. Company Contacts help you get in touch with the desired companies. Sector Studies provide an overview of an industry, the most important competitors, and the geographical distribution of companies. Company Lists allow you to attract new clients, while Import-Export services give you access to companies engaged in such activities.
Comments - Syncro Clinical Research Srl